NO970130D0 - Oligomeric carrier molecules with defined, embedded marker groups and haptens - Google Patents

Oligomeric carrier molecules with defined, embedded marker groups and haptens

Info

Publication number
NO970130D0
NO970130D0 NO970130A NO970130A NO970130D0 NO 970130 D0 NO970130 D0 NO 970130D0 NO 970130 A NO970130 A NO 970130A NO 970130 A NO970130 A NO 970130A NO 970130 D0 NO970130 D0 NO 970130D0
Authority
NO
Norway
Prior art keywords
haptens
carrier molecules
marker groups
embedded marker
oligomeric carrier
Prior art date
Application number
NO970130A
Other languages
Norwegian (no)
Other versions
NO970130L (en
Inventor
Hans-Peter Josel
Andreas Finke
Rupert Herrmann
Eva Hoess
Andreas Marschall
Christoph Seidel
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4430998A external-priority patent/DE4430998A1/en
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO970130D0 publication Critical patent/NO970130D0/en
Publication of NO970130L publication Critical patent/NO970130L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention concerns novel conjugates, process for manufacturing them, and the use of such conjugates as antigens in immunological detection processes or in DNA diagnostic procedures.
NO970130A 1994-07-25 1997-01-10 Oligomeric carrier molecules with defined, embedded marker groups and haptens NO970130L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4426276 1994-07-25
DE4430998A DE4430998A1 (en) 1994-07-25 1994-08-31 Metal chelated peptides
DE4430973A DE4430973A1 (en) 1994-07-25 1994-08-31 Hapten-labeled peptides
DE4439345A DE4439345A1 (en) 1994-07-25 1994-11-04 New conjugates comprising oligomeric carrier and attached hapten(s)
PCT/EP1995/002915 WO1996003650A1 (en) 1994-07-25 1995-07-24 Oligomer carrier molecules in which marker groups and haptens are selectively incorporated

Publications (2)

Publication Number Publication Date
NO970130D0 true NO970130D0 (en) 1997-01-10
NO970130L NO970130L (en) 1997-01-10

Family

ID=27436022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970130A NO970130L (en) 1994-07-25 1997-01-10 Oligomeric carrier molecules with defined, embedded marker groups and haptens

Country Status (12)

Country Link
EP (1) EP0774119B1 (en)
JP (1) JP3923076B2 (en)
CN (1) CN1178062C (en)
AT (1) ATE261122T1 (en)
CA (1) CA2195752C (en)
DK (1) DK0774119T3 (en)
ES (1) ES2217282T3 (en)
FI (1) FI970299A (en)
NO (1) NO970130L (en)
NZ (1) NZ290810A (en)
PT (1) PT774119E (en)
WO (1) WO1996003650A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030078416A1 (en) * 1996-04-30 2003-04-24 Yitzhak Tor Substituted phenanthrolines
EP0928155A1 (en) 1996-08-16 1999-07-14 Roche Diagnostics GmbH Monitoring system for the regular intake of a medicament
FR2955111B1 (en) 2010-01-12 2013-05-31 Biomerieux Sa PROCESS FOR THE PREPARATION OF POLYBIOTINYL COMPOUNDS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379659D1 (en) * 1983-07-29 1989-05-24 Henning Berlin Gmbh Preactivated surfaces of synthetic materials for immobilizing organochemical and biological substances, process for preparing them and their use
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
EP0155224A3 (en) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection
DK365785A (en) * 1984-09-17 1986-03-18 Hoffmann La Roche metal complex
US5106762A (en) * 1990-04-20 1992-04-21 Georgetown University Ligand-label conjugates which contain polyoxoanions of sulfur or phosphorus
EP0507587A3 (en) * 1991-04-03 1993-03-03 Syntex (U.S.A.) Inc. Immunoassay for immunoglubulins

Also Published As

Publication number Publication date
NZ290810A (en) 1998-01-26
FI970299A0 (en) 1997-01-24
PT774119E (en) 2004-07-30
EP0774119B1 (en) 2004-03-03
ATE261122T1 (en) 2004-03-15
EP0774119A1 (en) 1997-05-21
CN1178062C (en) 2004-12-01
DK0774119T3 (en) 2004-07-12
CA2195752C (en) 2010-10-26
AU682278B2 (en) 1997-09-25
JP3923076B2 (en) 2007-05-30
CA2195752A1 (en) 1996-02-08
FI970299A (en) 1997-01-24
CN1153555A (en) 1997-07-02
WO1996003650A1 (en) 1996-02-08
NO970130L (en) 1997-01-10
JPH10506708A (en) 1998-06-30
ES2217282T3 (en) 2004-11-01
AU3164995A (en) 1996-02-22

Similar Documents

Publication Publication Date Title
DK0733069T3 (en) Purified Primat CTLA-8 antigens and related reagents
TR200102497T2 (en) New streptococcus antigens
DE69935986D1 (en) STREPTOCOCCUS PNEUMONIAE PROTEINS AND NUCLEIC ACIDS
PL343245A1 (en) Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
DK121683D0 (en) PROCEDURE FOR PREPARING IMMUNOENZYMATIC CONJUGATES
NO971875L (en) Cathepsin 02 protease
DK0807178T3 (en) Mycobacterial proteins, microorganisms producing the same and uses of said proteins in vaccines and for the detection of tuberculosis
DE69021742D1 (en) Methods for the detection of small cell carcinoma and the use of sequences encoding acylpeptide hydrolase for this purpose.
ATE285474T1 (en) HAEMOPHILUS ADHESION PROTEINS
UY26266A1 (en) ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164
NO970130D0 (en) Oligomeric carrier molecules with defined, embedded marker groups and haptens
DE69728897D1 (en) SAEUGETIERCHEMOKINE
ES2236703T3 (en) USE OF METHODS TO IDENTIFY HYDROPHYL SIGNAL OLIGOPEPTIDES.
ATE122723T1 (en) RETINOBLASTOMA GENE PRODUCT ANTIBODIES AND USES THEREOF.
ATE197645T1 (en) IMMUNOENZYMATIC CONJUGATE, PRODUCTION METHOD THEREOF AND USES
ATE280229T1 (en) ENTEROTOXINS OF SHIGELLA FLEXNERI 2A
GB9810084D0 (en) Proteins
DE69838615D1 (en) ppGpp-Synthetase and expression systems for the improved production of proteins
WO2005037228A3 (en) Halogen phosphonate monoesters
DE60230051D1 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN NAMELY 121P2A3 FOR THE TREATMENT AND DETECTION OF CANCER
UA31082A (en) Method for speeding-up biological test on tuberculosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application